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ABSTRACT
Chlamydia trachomatis (CT) infections of the female genital tract, although frequently asymptom-
atic, are a major cause of fallopian-tube occlusion and infertility. Early stage pregnancy loss may
also be due to an unsuspected and undetected CT infection. In vitro and in vivo studies have
demonstrated that this organism can persist in the female genital tract in a form undetectable by
culture. The mechanism oftubal damage as well as the rejection of an embryo may involve an initial
immune sensitization to the CT 60 kD heat shock protein (HSP), followed by a reactivation of
HSP-sensitized lymphocytes in response to the human HSP and the subsequent release of inflam-
matory cytokines. The periodic induction ofhuman HSP expression by various microorganisms or
by noninfectious mechanisms in the fallopian tubes of women sensitized to the CT HSP may
eventually result in tubal scarring and occlusion. Similarly, an immune response to human HSP
expression during the early stages of pregnancy may interfere with the immune regulatory mecha-
nisms required for the maintenance of a semiallogeneic embryo. (C) 1995 Wiley-Liss, Inc.
KEY WORDS
Heat shock protein, spontaneous abortion, fallopian-tube occlusion, infertility
ost women who are infertile as a result of
fallopian-tube occlusion have never been di-
agnosed as having sexually transmitted diseases. In
a recent study of 283 women with tubal-factor in-
fertility, 84% had no history consistent with an
upper-genital-tract infection. However, the de-
gree of tubal damage in asymptomatic women was
as severe as in women with symptomatic tubal in-
fections. The involvement of Chlamydia tracho-
matis (CT) in tubal damage was indicated by the
greatly increased prevalence of antibodies to this
organism in women with asymptomatic tubal infer-
tility.2’
This article focuses on the experimental data
consistent with the hypothesis that a long-term,
undetected, asymptomatic CT infection of the fe-
male genital tract both induces tubal damage and
interferes with the early stages ofpregnancy through
an autoimmune mechanism.
PROBLEMS IN DETECTION OF
ASYMPTOMATIC CT INFECTION
In addition to being asymptomatic, CT infections
are difficult to detect. Culture, the traditional "gold
standard" for CT detection, is a time-consuming,
technically challenging procedure because of the
obligate requirement of this organism for intracel-
lular growth within a mammalian cell. The occa-
sional presence of inhibitors of mammalian cell
growth in the tissue culture of a genital-tract sam-
ple leads to false-negative results. Antigen detection
assays or DNA hybridization reactions, although
more rapid than culture, suffer from a decreased
sensitivity.
4 A recently developed polymerase chain
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TABLE I. Properties of the CT 60 kD HSP
Second most abundant CT protein in cell lysates
Loosely associated with cell surface
Present in both reticulate and elementary bodies
Only protein synthesized in nonproductive latent infections
induced by IFN/
Member of highly conserved 60 kD family of HSP
50% amino acid sequence homology to the human 60 kD
HSP
Potent inducer of inflammation in animals previously infected
with CT
reaction (PCR) for CT (Amplicor, Roche Molecu-
lar Systems, Branchburg, NJ), approved by the
Food and Drug Administration, has now replaced
the culture as the "gold standard" for detection of
this organism, s
Recent evidence has indicated that CT may re-
side in the fallopian tubes in a form that cannot be
cultured. In vitro, the addition of interferon-
gamma (IFN-/) to CT-infected cells led to the
formation of aberrant reticulate bodies that were
unable to proliferate. These forms produced mini-
mal amounts of CT structural antigens but contin-
ued to synthesize and release the 60 kD heat shock
protein (HSP). Removal of the IFN-/, however,
led to their reversion to morphologically normal
reticulate bodies which then differentiated into the
infectious elementary body forms of the organism.
6
The detection of CT DNA in the inflamed fallo-
pian tubes of women with tubal occlusions who
were negative for CT by culture has also been
reported.
7 Moreover, the findings of localized in-
flammation and CTDNA or protein in the absence
of a positive CT culture have been reported for
trachoma and reactive arthritis.
9
CT 60 kD HSP
As mentioned above, the 60 kD HSP is the major
CT protein produced during a chronic, nonpro-
ductive infection. The properties of this protein are
listed in Table 1. Of major interest was the demon-
stration of this purified protein’s ability to elicit a
potent inflammatory response at sites distant from
the original infection, in previously infected non-
human primates,
l indicating that a CT genital-
tract infection could prime an individual to respond
to the appearance of I-ISP in the absence of an active
infection.
A second relevant property of the CT HSP is its
similarity to human I-ISP in having an amino acid
sequence of approximately 50% homology. It has
an even stronger homology to the HSP of other
pathogenic microorganisms.
11 Thus, an immune
reaction to the CT HSP can sensitize lymphocytes
to crossreacting epitopes in the HSP ofman as well
as other bacteria.
The human 60 kD I-ISP is normally sequestered
within the mitochondria where it functions in pro-
tein transport and assembly and the regulation of
ATPase activity.
12 However, under conditions of
cellular stress due to increased temperature, infec-
tion, inflammation, or other conditions, the HSP
is expressed elsewhere within the cell and on the
cell’s surface.
13 The HSP binds to other proteins
and prevents their denaturation until the stressful
stimuli are alleviated.
IMMUNE RESPONSE TO THE CT HSP IN
WOMEN WITH SALPINGITIS
Several groups of investigators have demonstrated
that a humoral immune response to the CT HSP
was associated with occlusion of the fallopian
tubes.
14-16 We subsequently determined that lym-
phocytes from most women without evidence ofCT
exposure as well as from women with CT infections
confined to the cervix did not respond to the CT
HSP or to synthetic peptide epitopes of this pro-
tein. In contrast, the lymphocytes from a high per-
centage of women with recurrent episodes of salp-
ingitis exhibited cell-mediated immune responses
to conserved HSP epitopes.
17,18 This finding sug-
gested that repeated or chronic exposure to the CT
HSP was necessary to sensitize women to the
epitopes also present in the human protein.
Once a woman becomes immunized to conserved
epitopes of the CT HSP, any event that induces the
expression of a crossreacting HSP will reactivate
the sensitized lymphocytes. The observation that,
in many cases of pelvic inflammatory disease, no
infecting microorganism can be detected
19 may be
partially explained by an autoimmune mechanism
of inflammation involving prior sensitization to the
CT I-ISP and the subsequent induction of human
HSP expression in the fallopian tubes as a conse-
quence possibly of fever (elevated temperature) or a
localized immune-system activation of noninfec-
tious origin. The ascension of microorganisms not
typically associated with pelvic infections into the
fallopian tubes may possibly induce human HSP
expression by a similar mechanism. Repeated epi-
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sodes of immune activation and inflammatory cy-
tokine release would eventually damage the epithe-
lium and induce scar formation and occlusion.
The ability of CT to exist intracellularly in a
viable but nonproliferative state
6 may also contrib-
ute to chronic inflammatory-mediated damage. The
immune response to a CT upper-genital-tract infec-
tion includes the release of IFN-’y
2 and tumor
necrosis factor alpha (TNFcQ.
21 The 60 kD HSP
is also a strong inducer of inflammatory cytok-
ines.
)) IFN-y will inhibit the continued develop-
ment ofCT reticulate bodies and lead to the forma-
tion ofaberrant intracellular forms.
6 In addition, it
will induce the expression of class-2 major histo-
compatibility complex (MHC) antigens on the sur-
face of epithelial cells and macrophages. As sug-
gested previously,
2 this reaction fosters the in-
duction of inflammatory responses directed against
epithelial membrane antigen-MHC complexes.
The TNFot will interfere with fibroblast and
epithelial-cell growth and further activate phago-
cytic cells to release products that are cytotoxic to
epithelial cells. During this period ofimmune stim-
ulation, the extracellular CT elementary bodies will
be eradicated by the immune system. When this
stage is completed, IFN-y and TNFc production
will cease and the aberrant reticulate forms will
resume normal development. A recommencement
ofelementary-body release from the infected cells will
reactivate the immune response and the reappearance
of both cytokines. Repetitive cycles of active infection
followed by dormancy will gradually erode the integ-
rity of the tubal epithelia. The consequent increasing
degree of scar formation will eventually compromise
the patency of the fallopian tubes.
IMMUNE RESPONSE TO THE CT HSP IN
EARLY STAGE PREGNANCY LOSS
Women with histories of pelvic inflammatory dis-
ease who become pregnant were shown to have a
greatly increased incidence of spontaneous abortion
compared with matched control women.
23 To as-
certain the role, if any, of CT in early stage preg-
nancy loss more directly, we initiated studies of
women undergoing in vitro fertilization (IVF) at
the New York Hospital-Cornell Medical Center.
The utilization of an IVF population allowed us to
pinpoint accurately the time of conception and em-
bryo transfer and to monitor closely the progression
of the pregnancy.
Cervical samples were obtained at the time of
oocyte retrieval from 307 IVF patients who were
negative for CT by culture. These samples were
reassayed by PCR for evidence of this organism.
24
Twenty (6.5%) of the women were positive for CT
by PCR. The presence of CT was associated both
with a failure to become pregnant after embryo
transfer and with a spontaneous abortion after suc-
cessful implantation. This study reinforced the clin-
ical relevancy of the culture-negative, PCR-posi-
tive detection of CT and provided data that an
asymptomatic CT infection may be a cause of early
stage pregnancy loss.
To examine the possible role in pregnancy loss
of an immune response to the CT HSP, we ana-
lyzed cervical samples from 216 IVF patients for
cervical IgA antibodies to the recombinantCT HSP
as well as to CT structural antigens.
2s Term deliv-
eries occurred in 34.3% of the 198 patients who
proceeded to embryo transfers; only 5 (7.3%) of
these women were positive for anti-HSP IgA and
(1.5%) was positive for IgA to CT structural com-
ponents. In contrast, the presence of cervical anti-
bodies to both HSP and CT structural components
strongly correlated with a poor IVF outcome. Of
the women whose embryo transfers did not lead to
term deliveries, anti-HSP IgA was present in 36
(27.7%) and anti-CT IgA in 24 (16.2%).
Almost all of the women sensitized to CT struc-
tural antigens also had antibodies to HSP. How-
ever, only 35% of the women with cervical IgA
antibodies to HSP were sensitized to the other CT
antigens. This finding suggested 3 possibilities: 1)
that the HSP was the most immunogenic of the CT
antigens, 2) that a latent CT infection was present
in which only HSP was being produced,
6 or 3) that
the women were sensitized to the HSP from an
organism other than CT and crossreacting antibod-
ies were being detected.
The demonstration that local cervical immunity
to CT was associated with a poor IVF outcome
confirmed our previous studies using PCR to de-
tect this organism.
2s We believe it is unlikely that
the presence of either CT or anti-CT antibodies in
the cervix was responsible for the observed preg-
nancy failures. A more likely explanation is that
their detection serves as a marker for the concomi-
tant presence of this organism in the upper genital
tract where infection or immune sensitization would
be responsible for early stage pregnancy termination.
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Repeated or chronic
and asymptomatic
C. trachomatis
upper genital
tract infection
Lymphocytes become
sensitized to conserved
epitopes of the 60 kD
heat shock protein
Non-productive
chlamydial infection
1. Ascension of "non-pathogenic"
microorganisms from the lower
to the upper genital tract
2. Fever originating elsewhere in
the body
3. Local immune system activation
of non-infection origin-autoimmune,
hormonal, sperm
4. Pregnancy
Expression ofhuman 60 kD
heat shock protein by genital
epithelial cells, macrophages,
and trophoblast
Reactivation ofheat shock
protein-sensitized lymphocytes
Release ofpro-inflammatory
cytokines (IFN3,, TNFc)
Epithelial cell damage
Scarformation
Tubal occlusion
Fig. I. Proposed mechanism of CT-induced autoimmune-mediated fallopian-tube occlusion or early
stage pregnancy loss.
There is evidence that the human 60 kD HSP is
expressed on the surface of decidual epithelial cells
during early pregnancy.
26 Similarly, murine hy-
bridomas specifically responsive to the 60 kD HSP
have been shown to react with human tropho-
blasts.
27 Therefore, there appears to be ample hu-
man HSP expression during the early stages of
pregnancy to activate HSP-sensitized lymphocytes
and induce a localized, autoimmune inflammatory
response.
The proposed sequence of events leading from a
CT infection to immune sensitization to conserved
HSP epitopes to tubal scarring or pregnancy fail-
ure is illustrated in Figure 1.
CT INFECTION AND ANTISPERM
ANTIBODIES
Women with circulating antibodies against their
partners’ motile sperm have a reduced probability
for conception.
28 Fortunately, because of the im-
munosuppressive properties of sperm and seminal
fluid,
29 most sexually active women do not produce
antisperm antibodies. However, the wives of men
with asymptomatic CT infections detected by PCR
have been shown to have an increased prevalence of
IgG and IgA antisperm antibodies in their sera.
Most probably, the CT, which can nonspecifically
adhere to sperm, acts as an adjuvant in inducing
an immune response to both CT and sperm-specific
antigens.
2 Therefore, another consequence of an
asymptomatic genital-tract CT infection may be an
increased susceptibility to the development of anti-
sperm antibodies and immunological infertility.
When a woman who is sensitized to sperm, thus
having antisperm antibodies, engages in coitus, the
production ofIFN-/is stimulated by the interac-
tion between antibody-coated sperm and T lympho-
cytes.
4 Therefore, when sperm reach the fallopian
tubes of such a woman, they can interact with resi-
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TABLE 2. Screening for CT in asymptomatic
sexually active women
Whenever there is a new sexual partner
When there is unexplained infertility or spontaneous abortion
When either partner of an infertile couple has antisperm
antibodies
Prior to an IYF cycle
When a pregnant woman has a history of sexually transmitted
disease or infertility
dent lymphocytes,
3s producing a localized increase
in the IFN-/ concentration and, as mentioned
above, the induction of inflammatory responses to
epithelial-cell membrane components. The subse-
quent expression of HSP at the sites of inflamma-
tion would result in a further exacerbation of local-
ized tissue damage in women sensitized to HSP.
SCREENING FOR CT GENITAL-TRACT
INFECTIONS
In light of the asymptomatic nature of most CT
genital-tract infections as well as the ability of this
organism to evade immunological defenses, persist
for long periods,
36 and gradually ascend from the
lower to the upper genital tract, the most prudent
means to reduce the incidence of CT-related infer-
tility and pregnancy loss is the periodic screening of
asymptomatic women (and men) who are at risk for
acquiring this infection. Through such screening,
newly acquired infections of the cervix (and the
male genital tract) could be identified and antibiotic
treatment promptly initiated prior to the infection
of other regions of the genital tract and resultant
immune sequelae.
Various studies have been published predicting
which groups of women would most benefit from
selective CT screening or advocating universal
screening.
37-41 Further verification among differ-
ent subpopulations of women will help to pinpoint
future testing priorities. In addition, a more con-
certed effort is needed to educate women about the
prevalence of CT infection, the lack of symptoms
following an infection, the serious consequences of
harboring an undetected infection, and the indica-
tions for screening. Our suggestions for CT testing
in asymptomatic women are listed in Table 2.
Only through the education of patients and
health-care providers coupled with the identifica-
tion and prompt, effective treatment of asymptom-
atic female and male carriers of CT genital-tract
infections can we hope to diminish the incidence of
CT-associated infertility and pregnancy complica-
tions.
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